Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF
18.90
-0.50 (-2.58%)
Feb 28, 2025, 9:00 AM CET
Xlife Sciences AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 27, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 103 | 279 | 157 | - | - | - |
| Market Cap Growth | -18.77% | 77.76% | - | - | - | - |
| Enterprise Value | 253 | 434 | 321 | - | - | - |
| Last Close Price | 17.95 | 49.90 | 29.70 | - | - | - |
| PE Ratio | 6.88 | 18.75 | 10.96 | - | - | - |
| PS Ratio | 102.32 | 282.22 | 152.66 | - | - | - |
| PB Ratio | 0.38 | 0.76 | 0.46 | - | - | - |
| P/FCF Ratio | 54.26 | 1766.87 | - | - | - | - |
| P/OCF Ratio | 88.23 | 1623.87 | - | - | - | - |
| EV/Sales Ratio | 255.05 | 439.10 | 311.96 | - | - | - |
| EV/FCF Ratio | 132.97 | 2749.02 | - | - | - | - |
| Debt / Equity Ratio | 0.15 | 0.16 | 0.18 | 0.20 | 0.40 | 0.58 |
| Debt / FCF Ratio | 29.19 | 359.14 | - | - | - | - |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Quick Ratio | 2.69 | 3.11 | 0.61 | 1.05 | 1.60 | 9.40 |
| Current Ratio | 2.70 | 3.11 | 0.65 | 1.06 | 1.60 | 9.48 |
| Return on Equity (ROE) | 4.47% | 2.64% | 2.67% | 23.71% | 18.56% | - |
| Return on Assets (ROA) | -2.36% | -2.53% | -2.70% | -0.98% | -1.14% | - |
| Return on Capital (ROIC) | -2.88% | -3.09% | -3.36% | -1.16% | -1.15% | - |
| Earnings Yield | 20.60% | 5.33% | 9.12% | - | - | - |
| FCF Yield | 1.84% | 0.06% | -2.95% | - | - | - |
| Buyback Yield / Dilution | -12.33% | 0.17% | -17.26% | -4.77% | -60.85% | - |
| Total Shareholder Return | -12.33% | 0.17% | -17.26% | -4.77% | -60.85% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.